Daesung Group announced on the 5th that it successfully held the '2025 Daesung Haegang Science Forum' at the Westin Chosun Hotel in Jung-gu, Seoul, on the afternoon of the 4th.

This year's 8th Daesung Haegang Science Forum was held under the theme 'Bio-Innovation in the AI Era.' It explored the latest research achievements and future development directions in the rapidly advancing bio field through the convergence of artificial intelligence (AI) and biotechnology.

Daesung Group explained that the role of AI technology in the biotechnology field has been expanding at an unimaginable speed, accelerating the development of synthetic biology, such as genome design and protein structure prediction, and leading innovation across the bioindustry. In this context, the event was organized to provide insights into the future of the bioindustry and the transformation of the scientific and technological community.

This year's forum featured Lee Sang-yeop, Vice President for Research at KAIST and Vice Chairman of the National Bio Committee, as the keynote speaker. Vice President Lee presented on 'AI for Engineering Biology,' introducing actual strategies and cases of using AI in research and development of engineering biology.

Philip M. Kim, a professor at the University of Toronto in Canada, gave a keynote presentation titled 'Peptide Design: Designing Proteins with AI.' Professor Kim has been recognized for opening a new horizon in drug design by designing protein and peptide structures not found in nature using AI.

In the second session, Hwang Hee, CEO of Kakao Healthcare, a leading digital medical platform company based on AI (formerly a professor at Bundang Seoul National University Hospital), spoke as a presenter. CEO Hwang introduced the new medical paradigm led by AI and big data and the actual application methods of digital healthcare.

Additionally, Jang Byung-tak, a professor in the Department of Computer Science and Engineering at Seoul National University, presented on 'AI for Bio-Industry,' explaining how AI can lead bio-innovation at each evolutionary stage as an intelligent research collaborator.

In the session for emerging scientists, Jin Sang-rak, a professor in the Department of Biotechnology at Yeungnam University, presented his research on 'Development of Microorganisms Utilizing High-Efficiency C1 Gas Based on Synthetic Biology,' and Lee Sang-min, a professor in the Department of Chemical Engineering at POSTECH, presented on 'AI-Based Functional Protein Design.' The forum was chaired by Cho Byung-kwan, a distinguished professor at the KAIST Graduate School of Engineering Biology (Director of Research), who led the entire session.

Kim Young-hoon, Chairman of Daesung Group, who hosted the event, stated, "We expect innovative and disruptive technologies to emerge in the biotechnology field through the convergence of AI and bio," adding, "Through this, we hope to realize the dream of extending human life and enhance national competitiveness with K-biotech."

Launched in 2017 as the 'Daesung Haegang Microbial Forum,' this forum has continued in-depth discussions with domestic and international scholars on major challenges facing humanity, such as future energy, climate change response, and treatment of intractable diseases, centered on biotechnology. Since last year, it has been renamed the 'Daesung Haegang Science Forum,' expanding the forum's theme to encompass the entire field of science and technology.

Meanwhile, Daesung Group has been continuously making strategic investments in the AI and biotechnology fields through its subsidiary Daesung Ventures. Among the invested companies, 'First Bio Therapeutics' is enhancing the efficiency and accuracy of new drug development using AI.

Popular News